Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 281

Similar articles for PubMed (Select 23504997)

1.

Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.

Ng L, Tung-Ping Poon R, Yau S, Chow A, Lam C, Li HS, Chung-Cheung Yau T, Law WL, Pang R.

Hepatology. 2013 Aug;58(2):667-79. doi: 10.1002/hep.26396.

PMID:
23504997
2.

PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.

Liu Y, Zhang JB, Qin Y, Wang W, Wei L, Teng Y, Guo L, Zhang B, Lin Z, Liu J, Ren ZG, Ye QH, Xie Y.

Hepatology. 2013 Aug;58(2):692-705. doi: 10.1002/hep.26398.

PMID:
23505027
3.

MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.

Chang RM, Yang H, Fang F, Xu JF, Yang LY.

Hepatology. 2014 Oct;60(4):1251-63. doi: 10.1002/hep.27221. Epub 2014 Aug 21.

PMID:
24825302
4.

Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.

Yau WL, Lam CS, Ng L, Chow AK, Chan ST, Chan JY, Wo JY, Ng KT, Man K, Poon RT, Pang RW.

PLoS One. 2013;8(3):e57882. doi: 10.1371/journal.pone.0057882. Epub 2013 Mar 6.

5.

Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.

Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.

Hepatology. 2013 Oct;58(4):1349-61. doi: 10.1002/hep.26467. Epub 2013 Aug 7.

PMID:
23696034
6.

Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma.

Cheng N, Li Y, Han ZG.

Hepatology. 2013 May;57(5):1906-18. doi: 10.1002/hep.26202.

PMID:
23258480
7.

Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition.

Chung KY, Cheng IK, Ching AK, Chu JH, Lai PB, Wong N.

Hepatology. 2011 Jul;54(1):307-18. doi: 10.1002/hep.24372.

PMID:
21520196
8.

Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.

Zhang W, Sun HC, Wang WQ, Zhang QB, Zhuang PY, Xiong YQ, Zhu XD, Xu HX, Kong LQ, Wu WZ, Wang L, Song TQ, Li Q, Tang ZY.

Gastroenterology. 2012 Dec;143(6):1641-1649.e5. doi: 10.1053/j.gastro.2012.08.032. Epub 2012 Aug 23.

PMID:
22922424
9.

Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.

Zhou YM, Cao L, Li B, Zhang RX, Sui CJ, Yin ZF, Yang JM.

Ann Surg Oncol. 2012 May;19(5):1700-6. doi: 10.1245/s10434-011-1772-6. Epub 2011 May 17.

PMID:
21584833
10.

Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma.

Hao C, Zhu PX, Yang X, Han ZP, Jiang JH, Zong C, Zhang XG, Liu WT, Zhao QD, Fan TT, Zhang L, Wei LX.

BMC Cancer. 2014 Dec 18;14:978. doi: 10.1186/1471-2407-14-978.

11.

MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.

Xia H, Ooi LL, Hui KM.

Hepatology. 2013 Aug;58(2):629-41. doi: 10.1002/hep.26369. Epub 2013 Jun 25.

PMID:
23471579
12.

Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.

Tian H, Ge C, Li H, Zhao F, Hou H, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li J.

Hepatology. 2014 Apr;59(4):1459-70. doi: 10.1002/hep.26929. Epub 2014 Feb 25.

PMID:
24214128
13.

Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.

Xiong W, Ren ZG, Qiu SJ, Sun HC, Wang L, Liu BB, Li QS, Zhang W, Zhu XD, Liu L, Wang WQ, Tang ZY.

BMC Cancer. 2010 May 20;10:219. doi: 10.1186/1471-2407-10-219.

14.

CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.

Chen L, Chan TH, Yuan YF, Hu L, Huang J, Ma S, Wang J, Dong SS, Tang KH, Xie D, Li Y, Guan XY.

J Clin Invest. 2010 Apr;120(4):1178-91. doi: 10.1172/JCI40665. Epub 2010 Mar 24.

15.

Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.

Xia L, Huang W, Tian D, Zhu H, Qi X, Chen Z, Zhang Y, Hu H, Fan D, Nie Y, Wu K.

Hepatology. 2013 Feb;57(2):610-24. doi: 10.1002/hep.26029.

PMID:
22911555
16.

BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.

Han P, Fu Y, Luo M, He J, Liu J, Liao J, Tian D, Yan W.

Dig Dis Sci. 2014 May;59(5):992-1000. doi: 10.1007/s10620-013-2992-3. Epub 2014 Jan 18.

PMID:
24442236
17.

Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB, Shi GM, Ke AW, Yang XR, Tao ZH, Zhao YM, Qin Y, Zeng HY, Tang ZY, Fan J, Zhou J.

Clin Cancer Res. 2011 Dec 1;17(23):7294-302. doi: 10.1158/1078-0432.CCR-11-1327. Epub 2011 Oct 5.

18.

Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.

Tse EY, Ko FC, Tung EK, Chan LK, Lee TK, Ngan ES, Man K, Wong AS, Ng IO, Yam JW.

J Pathol. 2012 Mar;226(4):645-53. doi: 10.1002/path.3957. Epub 2012 Jan 4.

PMID:
22072235
19.

Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling.

Liu L, Dai Y, Chen J, Zeng T, Li Y, Chen L, Zhu YH, Li J, Li Y, Ma S, Xie D, Yuan YF, Guan XY.

Hepatology. 2014 Feb;59(2):531-43. doi: 10.1002/hep.26677. Epub 2013 Dec 23.

PMID:
23929794
20.

Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells.

Zhang HJ, Yao DF, Yao M, Huang H, Wang L, Yan MJ, Yan XD, Gu X, Wu W, Lu SL.

World J Gastroenterol. 2013 Jun 28;19(24):3792-801. doi: 10.3748/wjg.v19.i24.3792.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk